Technical Analysis for GTHX - G1 Therapeutics, Inc.

Grade Last Price % Change Price Change
grade F 20.54 -1.96% -0.41
GTHX closed down 1.96 percent on Thursday, December 5, 2019, on approximately normal volume.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong Down Down Down
See historical GTHX trend table...

Date Alert Name Type % Chg
Lower Bollinger Band Walk Weakness 0.00%
Lower Bollinger Band Touch Weakness 0.00%
NR7 Range Contraction -1.96%
Lower Bollinger Band Walk Weakness -1.96%
Inside Day Range Contraction -1.86%
BB Squeeze Ended Range Expansion -1.86%
Below Lower BB Weakness -1.86%
Lower Bollinger Band Touch Weakness -1.86%
MACD Bearish Signal Line Cross Bearish -1.53%
Bollinger Band Squeeze Range Contraction -1.53%

Older signals for GTHX ...

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
G1 Therapeutics, Inc. is a United States-based clinical-stage biopharmaceutical company. The Company is engaged in developing small-molecule therapies for the treatment of cancer. Its two clinical-stage candidates are trilaciclib (G1T28) and G1T38, which are potent, selective inhibitors of the validated kinase targets CDK4/6. Trilaciclib and G1T38 are designed to be combined and enhance the anti-tumor activity of current therapies. It is also developing G1T48, an oral selective estrogen receptor degrader (SERD) for the treatment of breast cancer. The Company is evaluating trilaciclib in three Phase II clinical trials. G1T38 is being evaluated in combination with Faslodex in a Phase I b/II a trial for patients with estrogen receptor-positive, HER2-negative breast cancer.
Biopharmaceutical Cancer Drugs Treatment Of Cancer Breast Cancer Hormones Astrazeneca Protein Kinase Inhibitors Her2/Neu Treatment Of Breast Cancer Antiestrogens

Is GTHX a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Indicators
Indicator Value
52 Week High 41.8
52 Week Low 13.87
Average Volume 399,763
200-Day Moving Average 24.16
50-Day Moving Average 22.62
20-Day Moving Average 22.41
10-Day Moving Average 21.87
Average True Range 1.36
ADX 39.04
+DI 9.92
-DI 30.72
Chandelier Exit (Long, 3 ATRs ) 20.69
Chandelier Exit (Short, 3 ATRs ) 23.24
Upper Bollinger Band 24.36
Lower Bollinger Band 20.45
Percent B (%b) 0.02
BandWidth 17.44
MACD Line -0.67
MACD Signal Line -0.52
MACD Histogram -0.1496
Fundamentals Value
Market Cap 580.97 Million
Num Shares 28.3 Million
EPS -11.02
Price-to-Earnings (P/E) Ratio -1.86
Price-to-Sales 0.00
Price-to-Book 4.87
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 22.37
Resistance 3 (R3) 22.41 21.84 22.07
Resistance 2 (R2) 21.84 21.37 21.82 21.96
Resistance 1 (R1) 21.19 21.09 20.91 21.15 21.86
Pivot Point 20.62 20.62 20.48 20.60 20.62
Support 1 (S1) 19.97 20.15 19.69 19.93 19.22
Support 2 (S2) 19.40 19.87 19.38 19.12
Support 3 (S3) 18.75 19.40 19.02
Support 4 (S4) 18.71